FAVIPIRAVIR for Covid-19: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 343 adverse event reports in the FDA FAERS database where FAVIPIRAVIR was used for Covid-19.
Most Reported Side Effects for FAVIPIRAVIR
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 369 | 66.1% | 61 | 126 |
| Drug ineffective | 56 | 10.0% | 30 | 29 |
| Drug ineffective for unapproved indication | 40 | 7.2% | 17 | 24 |
| Condition aggravated | 29 | 5.2% | 9 | 19 |
| Covid-19 | 26 | 4.7% | 11 | 19 |
| Disease progression | 24 | 4.3% | 12 | 6 |
| Product use in unapproved indication | 18 | 3.2% | 4 | 6 |
| Covid-19 pneumonia | 15 | 2.7% | 7 | 14 |
| Acute respiratory distress syndrome | 14 | 2.5% | 9 | 9 |
| Acute kidney injury | 13 | 2.3% | 3 | 7 |
| Rash maculo-papular | 13 | 2.3% | 0 | 11 |
| Bronchopulmonary aspergillosis | 11 | 2.0% | 5 | 6 |
| Exposure during pregnancy | 11 | 2.0% | 2 | 3 |
| Foetal exposure during pregnancy | 11 | 2.0% | 3 | 4 |
| Electrocardiogram qt prolonged | 10 | 1.8% | 2 | 3 |
Other Indications for FAVIPIRAVIR
Covid-19 pneumonia (130)
Product used for unknown indication (22)
Acute respiratory distress syndrome (17)
Antiviral treatment (13)
Covid-19 treatment (5)
Other Drugs Used for Covid-19
REMDESIVIR (7,196)
HYDROXYCHLOROQUINE (5,280)
BAMLANIVIMAB (4,621)
NIRMATRELVIR\RITONAVIR (4,587)
TOCILIZUMAB (4,186)
DEXAMETHASONE (2,975)
CASIRIVIMAB\IMDEVIMAB (2,943)
SOTROVIMAB (2,732)
AZITHROMYCIN ANHYDROUS (2,510)
METHYLPREDNISOLONE (1,633)